These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 13731832)
21. Histochemical demonstration in rat of monoamine oxidase inhibition of beta-phenyl-isopropyl hydrazine. MUSTAKALLIO KK; LEVONEN E; RAEKALLIO J Science; 1961 Aug; 134(3475):344. PubMed ID: 13727138 [TBL] [Abstract][Full Text] [Related]
22. Significance of monoamine oxidase inhibition for the pharmacological and clinical effects of hydrazine derivatives. PLETSCHER A Ann N Y Acad Sci; 1959 Sep; 80():1039-45. PubMed ID: 14433482 [No Abstract] [Full Text] [Related]
23. A method for measurement of monoamine oxidase inhibition in man: application to studies on hypertension. SJOERDSMA A; GILLESPIE L; UDENFRIEND S Ann N Y Acad Sci; 1959 Sep; 80():969-80. PubMed ID: 13831423 [No Abstract] [Full Text] [Related]
24. Monoamine oxidase inhibitors. II. Some amino and dialkylaminobenzyl hydrazines and their acyl derivatives. GARDNER TS; WENIS E; LEE J J Med Pharm Chem; 1961 Mar; 3():241-52. PubMed ID: 13896916 [No Abstract] [Full Text] [Related]
28. Anticonvulsant properties of monoamine oxidase inhibitors. PROCKOP DJ; SHORE PA; BRODIE BB Ann N Y Acad Sci; 1959 Sep; 80():643-51. PubMed ID: 14434994 [No Abstract] [Full Text] [Related]
29. Suppression of increased capillary permeability in injury by monoamine oxidase inhibitors. SPECTOR WG; WILLOUGHBY DA Nature; 1960 Apr; 186():162-3. PubMed ID: 13833208 [No Abstract] [Full Text] [Related]
30. The THERAPEUTIC action of monoamine oxidase inhibitors. Angiology; 1960 Feb; 11():55-7. PubMed ID: 13856617 [No Abstract] [Full Text] [Related]
31. The mode of action of monoamine oxidase inhibitors with special reference to serotonin. CRUMPTON CW Am J Cardiol; 1960 Dec; 6():1117-20. PubMed ID: 13718638 [No Abstract] [Full Text] [Related]
33. Species differences in the action of monoamine oxidase inhibitors. PLETSCHER A; GOSCHKE H; GEY KF; THOLEN H Med Exp Int J Exp Med; 1961; 4():113-7. PubMed ID: 13736341 [No Abstract] [Full Text] [Related]
34. Monoamine oxidase inhibitors. I. 1-Alkyl and 1-aralkyl-2-(picolinoyl and 5-methyl-3-isoxazolyl-carbonyl)hydrazines. GARDNER TS; WENIS E; LEE J J Med Pharm Chem; 1960 Apr; 2():133-45. PubMed ID: 13826540 [No Abstract] [Full Text] [Related]
35. Interaction of monoamine oxidase inhibitors with physiological and biochemical mechanisms in brain. BRODIE BB; SPECTOR S; SHORE PA Ann N Y Acad Sci; 1959 Sep; 80():609-16. PubMed ID: 13804624 [No Abstract] [Full Text] [Related]
36. Monoamine oxidase inhibitors in the treatment of angina pectoris. RUSSEK HI Angiology; 1960 Feb; 11():76-80. PubMed ID: 14440277 [No Abstract] [Full Text] [Related]
37. A monoamine oxidase inhibitor in the treatment of organic disease. MUETHER RO; SCHUETZ A; DEL ROSARIO H; SOMMER AJ J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():80-5. PubMed ID: 13773597 [No Abstract] [Full Text] [Related]
38. The effect of 5-hydroxytryptamine and of monoamine oxidase inhibitors on sexual maturity. ROBSON JM; BOTROS M J Endocrinol; 1961 Apr; 22():165-75. PubMed ID: 13742374 [No Abstract] [Full Text] [Related]
39. On the mechanism of action of monoamine oxidase inhibitors in angina pectoris. PLETSCHER A; GEY KF J Am Geriatr Soc; 1961 Jun; 9():410-8. PubMed ID: 13736338 [No Abstract] [Full Text] [Related]